发明名称 Novel ligands of nuclear receptor
摘要 It has been newly found out that ascochlorin, which is a publicly known fat-soluble antibiotic, and its homologs serve as a ligand of retinoid X receptor and react in vivo with the amino group of serum protein to form Schiff bases without showing any side effect of retinoid. Ascochlorin and its homologs are usable in treating and/or preventing diseases or conditions which can be relieved by the retinoid X receptor ligand-dependent gene signal transcriptional regulation (for example, diseases caused by the expression of insulin resistance, hypertension, cerebrovascular diseases, rheumatoid arthritis, autoimmune diseases, Ca metabolic error, complication of diabetes, arteriosclerosis, etc.). Moreover, they can inhibit denaturation and/or necrosis of pancreatic Langerhans islet beta -cells and, therefore, are usable in making these cells to sustain the insulin productivity.
申请公布号 AU1797700(A) 申请公布日期 2000.07.03
申请号 AU20000017977 申请日期 1999.12.14
申请人 NUCLEAR RECEPTOR RESEARCH LIMITED 发明人 GAKUZO TAMURA;KUNIO ANDO;JUNJI MAGAE;TAKAFUMI UCHIDA
分类号 A61K31/12;A61K31/192;A61K31/216;A61K31/353;A61K31/455;A61P3/10;A61P9/10;A61P19/02;A61P37/00;A61P37/06;C07C403/20;C07C403/24;C07D213/79;C07D213/80;C07D311/58;C07D311/70 主分类号 A61K31/12
代理机构 代理人
主权项
地址